Mood Changes on Spironolactone: Separate Acne Outcomes From Drug Effects
HealthRX.com
The label does not list depression; mood reports remain unproven
Key numbers
- 20.4%Headache reported by women on spironolactone in SAFA, versus placebo (12.0%)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 3.77 pointsAdjusted acne quality-of-life gain over placebo at week 24, favouring spironolactoneSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 18.5%Investigator-rated acne treatment success at week 12 with spironolactone (placebo 5.6%)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 50 mg dailyStarting spironolactone dose in the SAFA acne trial, before the later increaseSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
See the public record for Spironolactone
At a glance
- Label nervous-system list / Lethargy, mental confusion, ataxia, dizziness, headache, drowsiness [1]
- Label frequency / Not estimable; voluntary reports, causality not established [1]
- Mood outcome in acne trials / None measured; SAFA used a 0 to 30 acne quality-of-life scale [2][3]
- Headache in SAFA / 20.4% vs 12.0% with placebo [2]
- Serious adverse reactions in SAFA / None reported [2]
- Acne-QoL difference at week 24 / 3.77 points (95% CI 2.50 to 5.03) [2]
- Approval status for acne / Off-label; labeled uses are heart failure, hypertension add-on, edema and hyperaldosteronism [1]
- Lithium / Reduced renal clearance and increased toxicity risk; periodic level monitoring [1]
Does spironolactone cause depression or anxiety?
The Aldactone label's adverse reactions section lists lethargy, mental confusion, ataxia, dizziness, headache and drowsiness under nervous system and psychiatric reactions [1]. Depression and anxiety are not among the reactions that section names [1]. The section also says these reactions were reported voluntarily, from a population of uncertain size, so their frequency cannot be estimated reliably and a causal relationship to the drug cannot be established [1].
Spironolactone is not approved for acne. Its labeled indications are heart failure with reduced ejection fraction, add-on hypertension therapy, edema in cirrhosis or nephrotic syndrome, and primary hyperaldosteronism [1]. Acne in women is an off-label use supported by randomized evidence [2].
What people on Reddit report
Reddit accounts from people on spironolactone who noticed mood changes. Some tie the change to a dose change, a new contraceptive, or another medicine.
My mom has actually experienced this!!! It ended up being a sign that the dosage was not right for her. She does not take it for PMOS, but she was experiencing low sodium episodes while taking spiro which can absolutely affect your mood!Read the source discussion
I started about 3 months ago give or take and I do feel more moody! But I also had the nexplenon (spelling?) inserted around the same time and I've never tried this version of BC so I couldn't tell what was the cause.Read the source discussion
Questions worth asking
What the acne trial measured
SAFA was a pragmatic, double-blind, randomized trial in 410 women aged 18 or older with facial acne present for at least six months and judged to warrant oral antibiotics: 201 received spironolactone and 209 placebo, and participants continued their usual topical treatments. The dose was 50 mg daily to week 6, then 100 mg daily to week 24 [2].
The primary outcome was the Acne-Specific Quality of Life symptom subscale at week 12, a 0 to 30 scale on which higher scores mean better quality of life [3]. The scale is acne-specific; it is not a depression or anxiety measure, so SAFA cannot say whether spironolactone changes mood. The adjusted difference between groups was 1.27 points (95% CI 0.07 to 2.46) at week 12 and 3.77 points (95% CI 2.50 to 5.03) at week 24, both favouring spironolactone [2].
Investigator-assessed treatment success at week 12 was 18.5% with spironolactone versus 5.6% with placebo (adjusted odds ratio 5.18, 95% CI 2.18 to 12.28), and 81.9% versus 63.3% of participants rated their acne improved at week 24 [2]. Headache was reported by 20.4% of the spironolactone group and 12.0% of the placebo group; no serious adverse reactions occurred, and other adverse reactions were similar between groups [2].
Other label warnings
The label's warnings cover hyperkalemia, hypotension and worsening renal function, and electrolyte and metabolic abnormalities including hyponatremia, hypomagnesemia, hypocalcemia, hypochloremic alkalosis and hyperglycemia [1]. The label says to monitor serum potassium within one week of starting or titrating the dose and regularly thereafter, to monitor volume status and renal function periodically, and to monitor serum electrolytes, uric acid and blood glucose periodically [1].
Medicines that change the picture
The label states that spironolactone reduces the renal clearance of lithium, increasing the risk of lithium toxicity, and that lithium levels should be monitored periodically during co-administration [1].
The label also names several drugs that raise potassium and add hyperkalemia risk with spironolactone: ACE inhibitors, angiotensin receptor blockers, NSAIDs, heparin and low molecular weight heparin, and trimethoprim. It says to check serum potassium when ACE inhibitor or angiotensin receptor blocker therapy is altered, and it names potassium supplements and potassium-containing salt substitutes as raising hyperkalemia risk [1].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
Frequently asked questions
Can spironolactone cause depression?
How common are headaches on spironolactone for acne?
Is spironolactone with lithium a problem?
Does the dose matter for the nervous system reactions?
Does the label call for potassium checks?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
What does spironolactone do mentally?
The Aldactone label lists lethargy, mental confusion, ataxia, dizziness, headache and drowsiness under nervous system and psychiatric reactions, but depression and anxiety are not among them. These reactions were reported voluntarily, so how often they occur cannot be estimated reliably. Any mental effect beyond the listed reactions is not established.
Are mood swings associated with spironolactone?
No association with mood changes is established. The acne trial measured acne-specific quality of life, not depression or anxiety, so it cannot show whether spironolactone affects mood. The Aldactone label does not name depression or anxiety, and a causal relationship to its listed nervous system reactions cannot be established.
Can spironolactone help anxiety?
The SAFA acne trial measured acne-specific quality of life, not depression or anxiety, so it cannot show whether spironolactone affects anxiety. Anxiety is not among the nervous system and psychiatric reactions the Aldactone label lists.
References
Show all 5 referencesHide references
- U.S. National Library of Medicine, DailyMed. Aldactone (spironolactone) tablets, Pfizer prescribing information. Aldactone (spironolactone) tablets, Pfizer label
- Santer M, Lawrence M, Pyne S, Renz S, Stuart BL, Sach T, et al. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technol Assess. 2024.
- Santer M, Lawrence M, Renz S, Eminton Z, Stuart B, Sach TH, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023.
- Plovanich M, Weng QY, Mostaghimi A. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatol. 2015.
- Reddit participants. Mood swings from Spironolactone? (r/PCOS). Accessed 2026-11-11.
